Pharmacist Suspended Following Attempt to Remove Controlled Drugs Without Prescription

Date of Decision: October 22, 2024

Registrant's Role: Pharmacist

Outcome: Suspension for six months with a review towards the end of the period.

GPhC Standards Breached: Standard 2: Work in partnership with others. Standard 5: Use professional judgment. Standard 6: Be honest and trustworthy. Standard 9: Demonstrate leadership and set a good example.

Case Summary

The GPhC Fitness to Practise Committee reviewed the case of a pharmacist, referred to here as “the registrant,” who faced allegations of misconduct for attempting to remove controlled drugs from Lloyds Direct Pharmacy without a valid prescription or payment. The case highlighted significant breaches of professional integrity and public trust.


Case Background

On 22 February 2022, the registrant attempted to remove a strip of 10 Tramadol capsules from their workplace at the end of a shift. This act was discovered during a routine search by the pharmacy manager, during which the medication was found concealed in blue paper within the registrant’s pocket.

The registrant claimed that the incident was accidental, citing lack of concentration and carelessness due to personal health struggles. However, CCTV footage and witness accounts supported the conclusion that the act was intentional.


Fitness to Practise Findings

The Committee determined that the registrant’s actions:

  • Demonstrated Dishonesty: The registrant knowingly attempted to take controlled drugs without proper authorization.
  • Broke Professional Standards: The act constituted a breach of the fundamental principles of honesty and trust essential to the pharmacy profession.
  • Lacked Adequate Insight: While the registrant expressed remorse, their reflective statements failed to address the issue of dishonesty directly, instead framing the misconduct as a “mistake.”

Outcome and Sanction

The Committee imposed a six-month suspension, concluding that the registrant’s failings were remediable but that further time was needed for the registrant to develop insight and accountability. Key aggravating factors included:

  • The deliberate nature of the dishonesty.
  • A breach of trust in handling controlled drugs.
  • Limited acceptance of personal responsibility.

Mitigating factors included:

  • The registrant’s engagement with the process and acknowledgment of the allegations.
  • Testimonials highlighting the registrant’s otherwise unblemished career and commitment to improvement.

The suspension order was deemed proportionate to protect the public, uphold confidence in the profession, and provide the registrant an opportunity to demonstrate full remediation.


Key Learning Points for Pharmacy Professionals

  1. Integrity is Non-Negotiable: Any dishonest behavior, especially concerning controlled drugs, is a severe breach of trust.
  2. Accountability and Reflection: Fully acknowledging misconduct and demonstrating genuine insight are critical for rebuilding professional trust.
  3. Professional Standards are Paramount: Adherence to GPhC standards, particularly around honesty and leadership, is essential for maintaining public confidence in the profession.

Original Case Document

The full determination transcript is available to logged in users.

Log in or register for free to access.

Leave a Reply